Defining Coronary Artery Perforation with Ultrasound Contrast Agent

DOI QR Code

Youn, Young Jin (Division of Cardiology, Department of Internal Medicine, Wonju College of Medicine, Yonsei University) ;
Khalid, Salman (Division of Cardiovascular Medicine, Calhoun Cardiovascular Center, University of Connecticut School of Medicine) ;
Azrin, Michael (Division of Cardiovascular Medicine, Calhoun Cardiovascular Center, University of Connecticut School of Medicine) ;
Lee, Juyong (Division of Cardiovascular Medicine, Calhoun Cardiovascular Center, University of Connecticut School of Medicine)

Ellis SG, Ajluni S, Arnold AZ, et al. Increased coronary perforation in the new device era. Incidence, classification, management, and outcome. Circulation 1994;90:2725-30. https://doi.org/10.1161/01.CIR.90.6.2725
Oreglia JA, Bruschi G, Klugmann S. Percutaneous treatment of iatrogenic left-anterior descending artery to right ventricle fistula. Catheter Cardiovasc Interv 2010;76:975-7. https://doi.org/10.1002/ccd.22551
Main ML, Hibberd MG, Ryan A, Lowe TJ, Miller P, Bhat G. Acute mortality in critically ill patients undergoing echocardiography with or without an ultrasound contrast agent. JACC Cardiovasc Imaging 2014;7:40-8. https://doi.org/10.1016/j.jcmg.2013.08.012
Muskula PR, Main ML. Safety with echocardiographic contrast agents. Circ Cardiovasc Imaging 2017;10:e005459.